Literature DB >> 20652743

Protective effects of melatonin and octreotide against radiation-induced intestinal injury.

Cem Onal1, Fazilet Kayaselcuk, Erkan Topkan, Melek Yavuz, Didem Bacanli, Aydin Yavuz.   

Abstract

PURPOSE: To compare the protective effects of the potent antioxidants, melatonin and octreotide, against radiation-induced intestinal injury.
METHODS: A total of 42 male 3-month-old Swiss albino mice (40 ± 10 g) were matched according to body weight and randomly assigned to one of six groups: control; radiation treatment (RT) only; melatonin only (15 mg/kg, i.p.); melatonin + RT; octreotide only (50 μg/kg i.p.); and octreotide + RT. Intestinal damage was induced by exposure to a single whole-body radiation dose of 8 Gy. All mice tolerated the experimental interventions, and no deaths were observed.
RESULTS: Irradiation induced architectural disorganization, including inflammatory mononuclear cell infiltration, villitis, and desquamation with eosinophilic necrosis, and diminished mucosal thickness, crypt height, and villous height. In the melatonin + RT and octreotide + RT groups, the villous pattern was well preserved; desquamation at villous tips and edema was prominent, but necrosis was absent. The radiation-induced decrease in mucosal thickness was significantly reduced by pretreatment with melatonin (p < 0.001) or octreotide (p = 0.01), although the protective effect was significantly greater for melatonin (p = 0.04). Pretreatment with melatonin also preserved villous height (p = 0.009) and crypt height (p = 0.03); although a similar trend was observed for pre-irradiation octreotide, the differences were not significant.
CONCLUSIONS: Melatonin and octreotide potently protected against radiation-induced intestinal injury in mice, but melatonin was significantly more effective in preserving the histological structure of the intestines, a finding that warrants confirmation in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652743     DOI: 10.1007/s10620-010-1322-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa.

Authors:  Sarita Garg; Marjan Boerma; Junru Wang; Qiang Fu; David S Loose; K Sree Kumar; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

3.  Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats.

Authors:  Nermina Jahovic; Hülya Cevik; A Ozer Sehirli; Berrak C Yeğen; Göksel Sener
Journal:  J Pineal Res       Date:  2003-05       Impact factor: 13.007

Review 4.  Melatonin: therapeutic and clinical utilization.

Authors:  A Altun; B Ugur-Altun
Journal:  Int J Clin Pract       Date:  2007-02-13       Impact factor: 2.503

5.  Octreotide improves burn-induced intestinal injury in the rat.

Authors:  Göksel Sener; A Ozer Sehirli; Handan Satiroglu; Ayhan Kaçmaz; Gül Ayanoglu-Dülger; Berrak C Yegen
Journal:  Peptides       Date:  2003-01       Impact factor: 3.750

6.  Nitric oxide and radiation enteritis.

Authors:  Y Erbil; C Dibekoglu; U Turkoglu; E Ademoglu; E Berber; A Kizir; S Mercan; G Toker
Journal:  Eur J Surg       Date:  1998-11

7.  Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population.

Authors:  A Widmark; P Fransson; B Tavelin
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

8.  The half-life of melatonin elimination from rat plasma.

Authors:  F P Gibbs; J Vriend
Journal:  Endocrinology       Date:  1981-11       Impact factor: 4.736

9.  The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.

Authors:  Melek N Yavuz; A Aydin Yavuz; Fazil Aydin; Gamze Can; Halil Kavgaci
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

10.  Image-based assessment of esophageal stricture in experimental corrosive esophagitis in animals: an objective, adjunct diagnostic tool.

Authors:  Enver Vardar; Rukiye Vardar; Vahit Yükselen; Ozer Makay; Nazif Erkan; Umit Bayol; Omer Ozütemiz
Journal:  Turk J Gastroenterol       Date:  2009-03       Impact factor: 1.852

View more
  5 in total

Review 1.  Melatonin as an anti-inflammatory agent in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; A H Rezaeyan; A Salajegheh; S Rezapoor
Journal:  Inflammopharmacology       Date:  2017-03-02       Impact factor: 4.473

2.  Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasis.

Authors:  Joan H de Jong; Hans M Rodermond; Cheryl D Zimberlin; Valeria Lascano; Felipe De Sousa E Melo; Dick J Richel; Jan Paul Medema; Louis Vermeulen
Journal:  Sci Rep       Date:  2012-02-15       Impact factor: 4.379

3.  HGF Gene Modification in Mesenchymal Stem Cells Reduces Radiation-Induced Intestinal Injury by Modulating Immunity.

Authors:  Hua Wang; Rui-Ting Sun; Yang Li; Yue-Feng Yang; Feng-Jun Xiao; Yi-Kun Zhang; Shao-Xia Wang; Hui-Yan Sun; Qun-Wei Zhang; Chu-Tse Wu; Li-Sheng Wang
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 4.  Oral Mucositis: Melatonin Gel an Effective New Treatment.

Authors:  Ahmed Esmat Abdel Moneim; Ana Guerra-Librero; Javier Florido; Ying-Qiang Shen; Beatriz Fernández-Gil; Darío Acuña-Castroviejo; Germaine Escames
Journal:  Int J Mol Sci       Date:  2017-05-07       Impact factor: 5.923

5.  Ginseng oligopeptides protect against irradiation-induced immune dysfunction and intestinal injury.

Authors:  Li-Xia He; Zhao-Feng Zhang; Jian Zhao; Lin Li; Teng Xu; Jin-Wei Ren; Rui Liu; Qi-He Chen; Jun-Bo Wang; Mohamed M Salem; Giuseppe Pettinato; Jin-Rong Zhou; Yong Li
Journal:  Sci Rep       Date:  2018-09-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.